466 related articles for article (PubMed ID: 27591952)
21. Recombinant heat shock protein 60 (Hsp60/GroEL) of Salmonella enterica serovar Typhi elicits cross-protection against multiple bacterial pathogens in mice.
Chitradevi ST; Kaur G; Singh K; Sugadev R; Bansal A
Vaccine; 2013 Apr; 31(16):2035-41. PubMed ID: 23474314
[TBL] [Abstract][Full Text] [Related]
22. Development of a cost-effective vaccine candidate with outer membrane vesicles of a tolA-disrupted Shigella boydii strain.
Mitra S; Sinha R; Mitobe J; Koley H
Vaccine; 2016 Apr; 34(15):1839-46. PubMed ID: 26878295
[TBL] [Abstract][Full Text] [Related]
23. Vaccination With Mouse Dendritic Cells Loaded With an IpaD-IpaB Fusion Provides Protection Against Shigellosis.
Arizmendi O; Kumar P; Zheng Q; Stewart JP; Picking WD; Picking W; Martinez-Becerra FJ
Front Immunol; 2019; 10():192. PubMed ID: 30800131
[TBL] [Abstract][Full Text] [Related]
24. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
[TBL] [Abstract][Full Text] [Related]
25. In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity.
Pahil S; Taneja N; Ansari HR; Raghava GPS
PLoS One; 2017; 12(8):e0180505. PubMed ID: 28767653
[TBL] [Abstract][Full Text] [Related]
26. Immunization of Mice with a Live Transconjugant Shigella Hybrid Strain Induced Th1 and Th17 Cell-Mediated Immune Responses and Confirmed Passive Protection Against Heterologous Shigellae.
Nag D; Koley H; Sinha R; Mukherjee P; Sarkar C; Withey JH; Gachhui R
Scand J Immunol; 2016 Feb; 83(2):92-101. PubMed ID: 26478541
[TBL] [Abstract][Full Text] [Related]
27. Shigella outer membrane protein PSSP-1 is broadly protective against Shigella infection.
Kim JO; Rho S; Kim SH; Kim H; Song HJ; Kim EJ; Kim RY; Kim EH; Sinha A; Dey A; Yang JS; Song MK; Nandy RK; Czerkinsky C; Kim DW
Clin Vaccine Immunol; 2015 Apr; 22(4):381-8. PubMed ID: 25651919
[TBL] [Abstract][Full Text] [Related]
28. Parenteral immunization with IpaB/IpaD protects mice against lethal pulmonary infection by Shigella.
Martinez-Becerra FJ; Scobey M; Harrison K; Choudhari SP; Quick AM; Joshi SB; Middaugh CR; Picking WL
Vaccine; 2013 May; 31(24):2667-72. PubMed ID: 23602665
[TBL] [Abstract][Full Text] [Related]
29. Vaccine potential for inactivated shigellae.
Osorio M; Bray MD; Walker RI
Vaccine; 2007 Feb; 25(9):1581-92. PubMed ID: 17178431
[TBL] [Abstract][Full Text] [Related]
30. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
Barry EM; Wang J; Wu T; Davis T; Levine MM
Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
[TBL] [Abstract][Full Text] [Related]
31. A Novel
Desalegn G; Kapoor N; Pill-Pepe L; Bautista L; Yin L; Ndungo E; Oaks EV; Fairman J; Pasetti MF
mSphere; 2023 Jun; 8(3):e0001923. PubMed ID: 37017547
[No Abstract] [Full Text] [Related]
32. Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection.
van de Verg LL; Mallett CP; Collins HH; Larsen T; Hammack C; Hale TL
Infect Immun; 1995 May; 63(5):1947-54. PubMed ID: 7729907
[TBL] [Abstract][Full Text] [Related]
33. Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model.
Pore D; Mahata N; Pal A; Chakrabarti MK
PLoS One; 2011; 6(7):e22663. PubMed ID: 21818362
[TBL] [Abstract][Full Text] [Related]
34. Passive immunity with multi-serotype heat-killed Shigellae in neonatal mice.
Barman S; Koley H; Nag D; Shinoda S; Nair GB; Takeda Y
Microbiol Immunol; 2014 Aug; 58(8):463-6. PubMed ID: 24909404
[TBL] [Abstract][Full Text] [Related]
35. Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis.
Mitra S; Chakrabarti MK; Koley H
Vaccine; 2013 Jun; 31(31):3163-73. PubMed ID: 23684822
[TBL] [Abstract][Full Text] [Related]
36. Protective immunity by oral immunization with heat-killed Shigella strains in a guinea pig colitis model.
Barman S; Koley H; Ramamurthy T; Chakrabarti MK; Shinoda S; Nair GB; Takeda Y
Microbiol Immunol; 2013 Nov; 57(11):762-71. PubMed ID: 24033533
[TBL] [Abstract][Full Text] [Related]
37. SipD and IpaD induce a cross-protection against Shigella and Salmonella infections.
Jneid B; Rouaix A; Féraudet-Tarisse C; Simon S
PLoS Negl Trop Dis; 2020 May; 14(5):e0008326. PubMed ID: 32463817
[TBL] [Abstract][Full Text] [Related]
38. Recombinant Shiga toxin B subunit elicits protection against Shiga toxin via mixed Th type immune response in mice.
Gupta P; Singh MK; Singh Y; Gautam V; Kumar S; Kumar O; Dhaked RK
Vaccine; 2011 Oct; 29(45):8094-100. PubMed ID: 21856355
[TBL] [Abstract][Full Text] [Related]
39. Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers.
Tribble D; Kaminski R; Cantrell J; Nelson M; Porter C; Baqar S; Williams C; Arora R; Saunders J; Ananthakrishnan M; Sanders J; Zaucha G; Turbyfill R; Oaks E
Vaccine; 2010 Aug; 28(37):6076-85. PubMed ID: 20619378
[TBL] [Abstract][Full Text] [Related]
40. Cell-mediated immune responses and protective efficacy against infection with Mycobacterium tuberculosis induced by Hsp65 and hIL-2 fusion protein in mice.
Shi C; Yuan S; Zhang H; Zhang T; Wang L; Xu Z
Scand J Immunol; 2009 Feb; 69(2):140-9. PubMed ID: 19144078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
